Delivery Order SPE2DB25D3404-SPE2DB25FUNGX
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,117.95 firm fixed-price delivery order is for the supply of Liraglutide 3-Pak 18 mg/3 ml 3ml medication. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,015.52, is for the delivery of liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 24, 2025. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.13, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used for the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,281.33 firm fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The award has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,505.45, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3ml, a diabetes medication. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,740.45 firm fixed price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,397.78, is a Firm Fixed Price Delivery Order for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML. The contract has an ultimate completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,780.09 firm-fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medication used for diabetes management. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...